Buscar
Amgen Inc
AMGNAñadir a la lista de seguimiento
437.270USD
-6.850-1.54%
Cierre 09-04 16:00（ET）
235.95BCap. mercado
30.18P/E TTM
Más Datos de Amgen Inc Compañía
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.
Perfil de Amgen Inc
Símbolo de cotizaciónAMGN
Nombre de la empresaAmgen Inc
Fecha de salida a bolsaJun 17, 1983
Director ejecutivoBradway (Robert A)
Número de empleados28000
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 17
DirecciónOne Amgen Center Drive
CiudadTHOUSAND OAKS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal91320-1799
Teléfono18054471000
Sitio Webhttps://www.amgen.com/
Símbolo de cotizaciónAMGN
Fecha de salida a bolsaJun 17, 1983
Director ejecutivoBradway (Robert A)
Ejecutivos de Amgen Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Mr. Murdo Gordon
Mr. Murdo Gordon
Executive Vice President - Amgen Global Markets and Policy
Executive Vice President - Amgen Global Markets and Policy
48.67K
+1.91%
Mr. Murdo Gordon
Mr. Murdo Gordon
Executive Vice President - Amgen Global Markets and Policy
Executive Vice President - Amgen Global Markets and Policy
48.67K
+1.91%
Mr. Murdo Gordon
Mr. Murdo Gordon
Executive Vice President - Amgen Global Markets and Policy
Executive Vice President - Amgen Global Markets and Policy
48.67K
+1.91%
Mr. Derek Miller
Mr. Derek Miller
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.07K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Amgen Inc?
Los cinco principales accionistas de Amgen Inc son: Mr. Robert A. (Bob) Bradway
¿Cuántas instituciones poseen acciones de Amgen Inc (AMGN)?
A fecha de 2026Q1, 4665 instituciones poseen acciones de Amgen Inc, con un valor de mercado combinado de aproximadamente 460.83M, lo que representa el 85.38% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 2252779.00.
¿Cuál es la mayor fuente de ganancias de Amgen Inc?
El 2026Q1, el segmento empresarial Other products generó la ganancia más alta para Amgen Inc, ascendiendo a 1.70B y representando el 16.88% de la ganancia total.